name:-0.02648401260376
name:-0.039788961410522
name:-0.034940958023071
He; Liqi Patent Filings

He; Liqi

Patent Applications and Registrations

Patent applications and USPTO patent grants for He; Liqi.The latest application filed is for "macrocyclic toll-like receptor 7 (tlr7) agonists".

Company Profile
23.23.26
  • He; Liqi - San Jose CA
  • He; Liqi - Furlong PA
  • He; Liqi - West Chester PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
2H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor
Grant 11,400,094 - Poudel , et al. August 2, 2
2022-08-02
Macrocyclic Toll-like Receptor 7 (tlr7) Agonists
App 20210053979 - PURANDARE; Ashok V. ;   et al.
2021-02-25
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
Grant 10,927,114 - He , et al. February 23, 2
2021-02-23
Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor
Grant 10,919,895 - Poudel , et al. February 16, 2
2021-02-16
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
Grant 10,913,741 - He , et al. February 9, 2
2021-02-09
Toll-like Receptor 7 (tlr7) Agonists Having Heteroatom-linked Aromatic Moieties, Conjugates Thereof, And Methods And Uses Therefor
App 20200392137 - HE; Liqi ;   et al.
2020-12-17
Toll-like Receptor 7 (tlr7) Agonists Having A Heterobiaryl Moiety, Conjugates Thereof, And Methods And Uses Therefor
App 20200317672 - HE; Liqi ;   et al.
2020-10-08
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
Grant 10,793,569 - He , et al. October 6, 2
2020-10-06
Toll-like Receptor 7 (tlr7) Agonists Having A Pyridine Or Pyrazine Moiety, Conjugates Thereof, And Methods And Uses Therefor
App 20200308175 - POUDEL; Yam B. ;   et al.
2020-10-01
Toll-like Receptor 7 (tlr7) Agonists Having Heteroatom-linked Aromatic Moieties, Conjugates Thereof, And Methods And Uses Theref
App 20200255429 - Kind Code
2020-08-13
Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor
Grant 10,723,736 - Poudel , et al.
2020-07-28
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
Grant 10,711,003 - He , et al.
2020-07-14
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
Grant 10,689,382 - He , et al.
2020-06-23
Toll-like Receptor 7 (tlr7) Agonists Having Heteroatom-linked Aromatic Moieties, Conjugates Thereof, And Methods And Uses Theref
App 20200095248 - HE; Liqi ;   et al.
2020-03-26
Toll-like Receptor 7 (tlr7) Agonists Having A Heterobiaryl Moiety, Conjugates Thereof, And Methods And Uses Therefor
App 20200048254 - HE; Liqi ;   et al.
2020-02-13
Toll-like Receptor 7 (tlr7) Agonists Having A Pyridine Or Pyrazine Moiety, Conjugates Thereof, And Methods And Uses Therefor
App 20200048255 - POUDEL; Yam B. ;   et al.
2020-02-13
1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFOR
App 20200038403 - POUDEL; Yam B. ;   et al.
2020-02-06
2H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFOR
App 20200039986 - POUDEL; Yam B. ;   et al.
2020-02-06
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
Grant 10,508,115 - He , et al. Dec
2019-12-17
Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor
Grant 10,494,370 - Poudel , et al. De
2019-12-03
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
Grant 10,487,084 - He , et al. Nov
2019-11-26
Toll-like Receptor 7 (tlr7) Agonists Having A Pyridine Or Pyrazine Moiety, Conjugates Thereof, And Methods And Uses Therefor
App 20190055245 - POUDEL; Yam B. ;   et al.
2019-02-21
Toll-like Receptor 7 (tlr7) Agonists Having A Heterobiaryl Moiety, Conjugates Thereof, And Methods And Uses Therefor
App 20190055246 - HE; Liqi ;   et al.
2019-02-21
Toll-like Receptor 7 (tlr7) Agonists Having Heteroatom-linked Aromatic Moieties, Conjugates Thereof, And Methods And Uses Therefor
App 20190055247 - HE; Liqi ;   et al.
2019-02-21
Imidazotriazinecarbonitriles useful as kinase inhibitors
Grant 9,556,178 - Purandare , et al. January 31, 2
2017-01-31
Imidazopyridazinecarbonitriles useful as kinase inhibitors
Grant 9,371,328 - Fink , et al. June 21, 2
2016-06-21
Imidazotriazinecarbonitriles Useful As Kinase Inhibitors
App 20160108050 - Purandare; Ashok Vinayak ;   et al.
2016-04-21
Imidazotriazinecarbonitriles useful as kinase inhibitors
Grant 9,273,057 - Purandare , et al. March 1, 2
2016-03-01
Imidazotriazinecarbonitriles Useful As Kinase Inhibitors
App 20150210697 - Purandare; Ashok Vinayak ;   et al.
2015-07-30
Imidazotriazinecarbonitriles Useful As Kinase Inhibitors
App 20150065465 - Purandare; Ashok Vinayak ;   et al.
2015-03-05
Imidazotriazinecarbonitriles useful as kinase inhibitors
Grant 8,940,736 - Purandare , et al. January 27, 2
2015-01-27
Substituted pyrrolotriazines as protein kinase inhibitors
Grant 8,791,257 - Markwalder , et al. July 29, 2
2014-07-29
Imidazopyridazinecarbonitriles Useful As Kinase Inhibitors
App 20140179674 - Fink; Brian E. ;   et al.
2014-06-26
Imidazotriazinecarbonitriles Useful As Kinase Inhibitors
App 20140018319 - Purandare; Ashok Vinayak ;   et al.
2014-01-16
Substituted Pyrrolotriazines As Protein Kinase Inhibitors
App 20130023514 - Markwalder; Jay A. ;   et al.
2013-01-24
Imidazopyridazinecarbonitriles Useful As Kinase Inhibitors
App 20120283241 - Fink; Brian E. ;   et al.
2012-11-08
Imidazopyridazinecarbonitriles useful as kinase inhibitors
Grant 8,252,795 - Fink , et al. August 28, 2
2012-08-28
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
Grant 7,923,556 - Wrobleski , et al. April 12, 2
2011-04-12
Imidazopyridazinecarbonitriles Useful As Kinase Inhibitors
App 20100113458 - Fink; Brian E. ;   et al.
2010-05-06
Azolo triazines and pyrimidines
Grant 7,678,793 - He , et al. March 16, 2
2010-03-16
Phenyl-substituted Pyrimidine Compounds Useful As Kinase Inhibitors
App 20100029649 - Wrobleski; Stephen T. ;   et al.
2010-02-04
Azolo triazines and pyrimidines
App 20060252756 - He; Liqi ;   et al.
2006-11-09
Azolo triazines and pyrimidines
Grant 7,094,782 - He , et al. August 22, 2
2006-08-22
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
App 20060178388 - Wrobleski; Stephen T. ;   et al.
2006-08-10
Azolo triazines and pyrimidines
App 20030008885 - He, Liqi ;   et al.
2003-01-09
Azolo triazines and pyrimidines
Grant 6,191,131 - He , et al. February 20, 2
2001-02-20
Azolo triazines and pyrimidines
Grant 6,124,289 - He , et al. September 26, 2
2000-09-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed